Document is current
Any future updates will be listed below
-
Authors
Singh, Vijendra
Uddin, Mohammed Hafiz
Zonder, Jeffrey A.
Azmi, Asfar S.
Balasubramanian, Suresh Kumar https://orcid.org/0000-0001-9044-1309
- License Information
-
More Information
Article History
Received: 2 August 2021
Accepted: 22 October 2021
First Online: 18 November 2021
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare no direct conflict of interests. Unrelated conflicts are as follows: ASA received funding and speaker fees from Karyopharm Therapeutics Inc. ASA received funding from Janssen, Rhizen, and EISAI. ASA is a consultant for GLG and Guidepoint.
